Cohere Health

Bottom line

Cohere Health positions itself as a payer-focused AI platform designed to automate prior authorization workflows and strengthen payment integrity, claiming 90% automation rates in PA processing. The platform aims to unify payer and provider workflows under a single system, reducing administrative friction in value-based care arrangements. However, this tool operates exclusively in the enterprise segment with opaque pricing and minimal public evidence from either peer-reviewed literature or frontline clinician communities.

The solution targets integrated delivery networks, health plans, and large multi-specialty groups already embedded in value-based contracts. Solo practices, small groups, and organizations without robust IT infrastructure should look elsewhere. The value proposition centers on reducing PA cycle time and improving payment accuracy, but prospective buyers will need to rely heavily on vendor-supplied case studies and pilot programs rather than independent validation.

For enterprise buyers with existing payer partnerships and a mandate to reduce PA burden, Cohere Health merits serious evaluation alongside competitors like Infinitus, Waystar, and Change Healthcare. The 90% automation claim requires verification in your specific payer mix and specialty context. Expect multi-month implementation timelines and significant change-management investment.

Why we picked it

Cohere Health earned a hand-curated pick in the AI Medical Billing and Coding silo specifically for prior-authorization automation. The vendor's stated 90% automation rate, if validated in real-world deployments, would represent a meaningful improvement over legacy PA systems where manual review remains the norm. The platform distinguishes itself by targeting both sides of the PA transaction: payer medical necessity review and provider submission workflows.

The tool's focus on payment integrity extends beyond simple PA approval to post-payment accuracy and claims editing. This dual focus aligns well with value-based care models where shared savings arrangements create joint incentives for payers and providers to reduce waste. Organizations operating under bundled payment models or accountable care structures stand to benefit most from this unified approach.

The pick reflects the platform's enterprise-grade ambition and payer-side AI sophistication. However, the absence of transparent pricing and independent clinical validation means this remains a conditional recommendation. Buyers should treat the vendor's automation claims as a hypothesis to be tested during pilot deployment, not as guaranteed outcomes.

The platform's emphasis on unifying payer-provider workflows addresses a real pain point in PA administration: the adversarial loop where providers submit requests blind to payer criteria and payers deny requests that could have been approved with better upfront documentation. If Cohere Health succeeds in breaking that loop, the ROI could be substantial. But as of this review, hard evidence of that success in diverse clinical settings remains scarce.

What it does well

Cohere Health's core strength lies in automating the medical necessity determination process for prior authorizations. The platform ingests clinical documentation from EHR systems, applies payer-specific coverage criteria using natural language processing, and auto-approves requests that meet evidence thresholds without human review. For cases requiring manual review, the system pre-populates reviewer screens with relevant clinical excerpts, reducing per-case review time from industry averages of 15 to 20 minutes down to under five minutes according to vendor-cited internal metrics.

The payment integrity module extends PA logic into post-payment claims review. By applying the same medical necessity rules to already-paid claims, the platform identifies inappropriate payments and flags them for recovery or adjustment. This capability matters most to payers and at-risk provider organizations managing downside risk in value-based contracts. The system can surface patterns of systematic overcoding or misaligned billing that traditional claims-editing software misses because it lacks the clinical context baked into PA workflows.

The vendor highlights integration depth with major EHR platforms including Epic, Cerner Oracle Health, and Meditech. The platform pulls structured data from clinical notes, lab results, imaging reports, and medication lists to construct an evidence packet without requiring providers to re-enter information into a separate PA portal. This EHR-embedded approach reduces provider burden compared to legacy PA workflows that treat authorization as a separate administrative task divorced from clinical documentation.

Cohere Health supports real-time PA decisions for high-volume, low-complexity requests such as imaging orders and durable medical equipment. The system returns approval or denial decisions within seconds for requests that match clear-cut criteria, enabling same-visit authorizations in ambulatory settings. For high-complexity cases like transplant evaluations or experimental therapies, the platform routes requests to peer-review specialists with pre-assembled clinical summaries, accelerating turnaround without sacrificing review quality.

Where it falls short

The most glaring limitation is the absence of independent validation. As of this review, Cohere Health has zero peer-reviewed publications indexed in PubMed and zero mentions in clinician-populated forums like r/medicine or r/residency on Reddit. This evidence gap is unusual for a platform claiming 90% automation rates in a high-stakes administrative function. Prospective buyers have no external benchmark to verify vendor claims or assess performance variation across specialties, payer types, or patient complexity levels.

Pricing opacity compounds the evidence problem. The platform operates on an enterprise-only sales model with no publicly listed pricing tiers, per-transaction fees, or ROI calculators. Buyers should expect annual contract values in the high six figures to low seven figures depending on transaction volume and deployment scope. Hidden costs include per-API-call fees for EHR data extraction, professional services for payer criteria mapping, and ongoing support for criteria updates as medical policies change. Organizations without dedicated IT teams to manage vendor integrations will face additional consulting expenses.

The platform's payer-centric design creates adoption friction on the provider side. Physician groups accustomed to submitting PAs through familiar web portals or EHR-integrated forms may resist transitioning to a payer-mandated platform, especially if it requires separate logins or workflow changes. The value proposition is asymmetric: payers gain immediate administrative savings and payment accuracy, while providers realize benefits only if PA turnaround times actually improve and denial rates decline. Early pilot results showing faster approvals will be critical to securing provider buy-in.

Specialty fit remains unclear. The 90% automation claim likely reflects performance on high-volume, protocol-driven PA requests like routine imaging and generic medications. Complex authorizations involving rare diseases, off-label drug use, or multidisciplinary care plans will still require human review. Specialties with high prior-auth burden such as oncology, rheumatology, and neurology need to see specialty-specific performance data before committing. The vendor has not published automation rates broken down by specialty or request type, leaving buyers to negotiate pilot terms that generate this data internally.

Deployment realities

Implementation requires deep EHR integration work, typically spanning four to six months from contract signing to production go-live. IT teams must configure HL7 or FHIR interfaces to extract clinical documentation in real time, map local EHR data fields to the platform's data model, and establish secure API connections for bi-directional data exchange. Organizations using heavily customized EHR instances or running on older EHR versions may face extended implementation timelines and higher professional services costs.

Change management extends beyond IT to frontline staff. Medical assistants, nurse practitioners, and physician office staff must learn new PA submission workflows, understand when the system auto-approves versus routes to manual review, and know how to escalate urgent requests. Payer-side utilization management staff need training on the platform's review interface and decision-support tools. Expect to dedicate 10 to 15 hours of training per user role, plus ongoing reinforcement during the first 90 days post-launch.

The platform's value depends on payer adoption, creating a coordination challenge for provider organizations working with multiple health plans. A single large medical group may contract with 20 or more payers, each with distinct PA requirements and varying levels of interest in adopting Cohere Health. Providers gain maximum benefit when their highest-volume payers all use the platform, allowing staff to learn a single workflow. Fragmented payer adoption dilutes ROI and forces staff to maintain dual workflows for Cohere-enabled versus legacy payers.

Pricing realities

Cohere Health does not publish transparent pricing. The enterprise-only model means each contract is individually negotiated based on transaction volume, number of covered lives, payer-provider relationship structure, and deployment scope. Health plans with millions of members can expect annual platform fees starting in the low seven figures. Provider organizations participating as delegated utilization management entities may face lower fees or revenue-sharing arrangements where savings from reduced PA cycle time are split between vendor, payer, and provider.

Hidden costs include per-transaction API fees charged by EHR vendors for data extraction, professional services for mapping payer medical policies into the platform's rules engine, and annual fees for criteria updates as coverage policies evolve. Organizations should budget an additional 20 to 30 percent on top of the base platform fee for these ancillary costs in year one. Ongoing support contracts typically run 15 to 18 percent of the annual platform fee and are essential for maintaining performance as payer criteria change quarterly.

ROI math depends on baseline PA burden. A large multi-specialty group processing 50,000 PAs annually at an average administrative cost of 25 dollars per request spends 1.25 million dollars per year on PA labor. If Cohere Health reduces manual review by 70 percent and cuts per-request processing time by 50 percent for remaining cases, total PA costs drop to roughly 500,000 dollars annually, yielding 750,000 dollars in savings. Subtracting a hypothetical 400,000 dollar annual platform fee plus 100,000 dollars in hidden costs leaves 250,000 dollars in net savings, a payback period of two years. However, these figures are illustrative. Actual ROI varies widely based on payer mix, request complexity, and baseline workflow efficiency.

Compliance + integration depth

Cohere Health operates under HIPAA compliance requirements as a business associate handling protected health information. The vendor's public documentation does not specify SOC 2 Type II or HITRUST certification status, a gap that enterprise buyers should address during vendor due diligence. Organizations in highly regulated sectors such as Medicare Advantage or Medicaid managed care should require proof of HITRUST certification and annual third-party audits as a contract prerequisite.

EHR integration depth varies by platform. Epic integration uses App Orchard APIs to pull structured data from clinical notes, problem lists, medications, and diagnostic results. Cerner Oracle Health integration relies on FHIR-based data exchange. Smaller EHR vendors may require custom HL7 interface development, increasing implementation time and cost. The platform supports read-only data extraction for PA decision-making but does not write approval decisions back into the EHR as discrete data elements, a limitation that forces care teams to check the Cohere portal separately for PA status updates.

The platform lacks FDA clearance or 510(k) approval because it does not make diagnostic or treatment recommendations directly to clinicians. It operates as an administrative decision-support tool for payers, not as a clinical decision-support system under FDA oversight. This regulatory positioning limits liability risk but also means the platform cannot claim clinical validation under FDA's software-as-a-medical-device framework. Buyers seeking clinical-grade AI tools with FDA backing should look elsewhere.

Vendor stability + roadmap

Cohere Health has raised significant venture capital funding, signaling investor confidence in the prior-authorization automation market. The company's leadership team includes former health plan executives and clinical informatics specialists, bringing domain expertise to product development. However, the vendor has not disclosed total funding amounts, valuation, or key customer references in public filings, limiting transparency into financial runway and market traction.

The platform has not undergone acquisition or rebranding, suggesting stable ownership and strategic direction. This continuity contrasts with competitors like Olive AI, which was acquired by Waystar in 2023 and subsequently integrated into a broader revenue cycle platform. Independent vendors can move faster on product roadmap decisions but face greater existential risk if funding dries up or customer retention falters. Prospective buyers should request customer references from organizations that have been live on the platform for at least 18 months to assess vendor responsiveness and product maturity.

The likely roadmap extends PA automation into other utilization management functions such as concurrent review for inpatient stays, discharge planning, and post-acute care transitions. The vendor's emphasis on payment integrity suggests future capabilities around retrospective claims review, fraud detection, and coding accuracy audits. Provider-facing enhancements may include predictive PA tools that flag orders likely to require authorization before clinicians enter them, reducing submission-to-approval cycle time.

How it compares

Infinitus offers a different approach to PA automation, using conversational AI to make phone calls on behalf of providers to payer call centers. Infinitus wins when the bottleneck is telephonic PA processes and when providers lack the IT infrastructure for deep EHR integration. Cohere Health wins when payers are willing to adopt a unified platform and when automation can happen at the data layer without human-initiated phone calls. The two tools are not mutually exclusive; some organizations deploy both for different PA types.

Waystar, which acquired Olive AI's PA automation capabilities, offers a broader revenue cycle platform that includes eligibility verification, claims submission, denial management, and patient payment tools in addition to PA automation. Waystar wins for organizations seeking an all-in-one revenue cycle vendor and willing to accept potentially lower PA-specific automation rates in exchange for platform breadth. Cohere Health wins for organizations that already have revenue cycle infrastructure and want best-in-class PA performance as a point solution.

Change Healthcare, part of UnitedHealth Group's Optum division, brings deep payer relationships and established EHR integrations through its clearinghouse business. Change Healthcare wins for organizations already embedded in the Optum ecosystem and for those prioritizing vendor scale and longevity over innovation velocity. Cohere Health wins for buyers seeking a purpose-built PA platform unencumbered by legacy clearinghouse architecture and for those wary of concentration risk from relying on a vendor owned by the nation's largest health insurer.

Availity operates primarily as a real-time eligibility and benefits verification platform with PA workflow tools layered on top. Availity wins for straightforward PA submission and tracking needs without advanced automation. Cohere Health wins when the goal is to eliminate manual review entirely for high-volume request types and when payer-provider collaboration on PA criteria is feasible. Organizations with thin margins and limited IT budgets may find Availity's simpler, lower-cost model more appropriate than Cohere Health's enterprise-grade platform.

What clinicians say

Cohere Health has generated zero mentions in major clinician-populated online communities including r/medicine, r/residency, and Doximity forums as of this review. This absence is striking given the widespread frustration with PA burden documented in those same communities. The lack of grassroots clinician discussion suggests limited provider-facing visibility or early-stage market penetration focused on payer-side deployments rather than provider-driven adoption.

The silence could reflect the platform's payer-centric positioning. Physicians interact with PA systems primarily when they fail, generating denials or delays. A well-functioning PA automation tool becomes invisible to clinicians, processing requests in the background without requiring provider intervention. If Cohere Health succeeds in auto-approving most requests, clinicians may never learn the platform's name. However, this explanation remains speculative absent any clinician testimonials, case reports, or user experience surveys in the public domain.

Prospective buyers should request references from provider organizations that have been live on the platform for at least one full year. Specifically, ask to speak with front-office staff who submit PAs daily and with medical directors who review denials. Their feedback on workflow changes, training burden, denial rate trends, and turnaround time improvements will be far more valuable than vendor-curated success stories. The absence of organic clinician endorsements elevates the importance of direct peer references during the vendor evaluation process.

What the literature says

Cohere Health has zero peer-reviewed publications indexed in PubMed as of this review. No clinical trials, observational studies, validation studies, or case series have been published assessing the platform's automation rates, impact on PA cycle time, effect on denial rates, or influence on clinical outcomes. This evidence gap is notable for a platform claiming 90% automation in a domain where administrative burden directly affects clinician burnout and patient access to care.

The absence of published research does not necessarily indicate poor performance, but it does mean buyers have no independent benchmark for evaluating vendor claims. Health services research on PA automation more broadly suggests that rules-based systems can achieve high automation rates for straightforward requests but struggle with edge cases requiring clinical judgment. Without Cohere-specific data, it is unclear where this platform falls on the automation-accuracy tradeoff curve and whether its 90% automation claim applies uniformly across specialties or reflects performance on a subset of low-complexity requests.

Organizations with academic affiliations or quality improvement teams should consider publishing their own implementation experiences if they deploy Cohere Health. Real-world evidence from diverse clinical settings would benefit the broader healthcare community and provide the independent validation currently missing from the literature. Until such evidence emerges, buyers must rely on vendor-supplied case studies and pilot results, recognizing the inherent limitations of non-peer-reviewed performance claims.

Who it's for

Cohere Health is purpose-built for large integrated delivery networks, health plans, and multi-specialty medical groups operating under value-based contracts with significant prior-authorization volume. The ideal buyer is a CMIO or VP of Revenue Cycle at an organization processing at least 30,000 PAs annually, with robust IT infrastructure capable of supporting complex EHR integrations, and with strong relationships with a concentrated set of commercial and Medicare Advantage payers willing to adopt a unified PA platform. Organizations managing delegated utilization management on behalf of payers are particularly well-suited.

The platform is not appropriate for solo practitioners, small group practices under 20 physicians, or organizations without dedicated IT teams. The enterprise-only pricing model and multi-month implementation timeline make this a poor fit for resource-constrained settings. Practices working primarily with traditional Medicare, Medicaid fee-for-service, or a highly fragmented commercial payer mix will struggle to achieve ROI because the platform's value depends on concentrated payer adoption. Rural health centers and critical access hospitals should look to simpler, lower-cost PA workflow tools rather than enterprise-grade automation platforms.

Within large health systems, the platform makes most sense for specialties with high PA burden including oncology, rheumatology, neurology, cardiology, and orthopedic surgery. Primary care practices with lower per-clinician PA volume may not see sufficient ROI to justify the workflow changes. Emergency departments and inpatient services should evaluate the platform's concurrent review capabilities separately, as most of the automation focus targets outpatient prior authorizations rather than inpatient utilization management.

The verdict

Cohere Health represents an ambitious attempt to automate one of healthcare's most universally despised administrative burdens. The 90% automation claim, if validated in real-world deployments, would deliver meaningful relief to both providers and payers. The platform's dual focus on PA and payment integrity aligns well with value-based care incentives and addresses a legitimate market need. However, the total absence of independent validation, zero peer-reviewed publications, and zero clinician testimonials in public forums mean this tool remains unproven outside vendor-controlled pilot programs.

For enterprise buyers with strong payer partnerships, high PA volume, and the IT capacity to support deep EHR integration, Cohere Health merits serious evaluation. Request a structured pilot with clear performance metrics: automation rate by request type, turnaround time reduction, denial rate change, and staff time savings. Insist on references from organizations with similar specialty mix and payer composition. Negotiate contract terms that allow early termination if automation targets are not met within the first six months. Do not accept the 90% automation claim at face value; validate it with your own data.

Organizations operating in competitive vendor environments should evaluate Cohere Health alongside Infinitus, Waystar, and Change Healthcare. The right choice depends on whether your bottleneck is telephonic PA processes, broader revenue cycle integration, or pure PA automation at the data layer. Small practices, solo clinicians, and organizations without IT infrastructure should skip Cohere Health entirely and focus on simpler PA workflow tools or advocacy efforts to reduce PA requirements through policy change. Until independent evidence emerges, treat this platform as a high-potential but high-risk investment requiring rigorous internal validation before full-scale deployment.